The Krüppel-like factor 2 and Krüppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesis

BMC Developmental Biology

Volumn 13, Issue 1, 2013, Pages

  Chiplunkar, Aditi R ^a   Curtis, Benjamin C ^a   Eades, Gabriel L ^a   Kane, Megan S ^a   Fox, Sean J ^a   Haar, Jack L ^a   Lloyd, Joyce A ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Embryonic vascular integrity; Endothelial cell development; Gene interactions; KLF2; KLF4

Indexed keywords

MUS; PROSPECT HILL VIRUS;

FGFR2 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR RECEPTOR 2; KLF2 PROTEIN, MOUSE; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 4; NITRIC OXIDE SYNTHASE; OCCLUDIN; OCLN PROTEIN, MOUSE; TAMOXIFEN;

ANIMAL; ANIMAL EMBRYO; ARTICLE; BLOOD VESSEL; BRAIN HEMORRHAGE; ELECTRON MICROSCOPY; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MORPHOGENESIS; MOUSE; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD VESSELS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTRACRANIAL HEMORRHAGES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MORPHOGENESIS; NITRIC OXIDE SYNTHASE; OCCLUDIN; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SIGNAL TRANSDUCTION; TAMOXIFEN;

EID: 84887973527     PISSN: None     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-13-40     Document Type: Article

References (35)

1. Signaling pathways in vascular development. Rossant J, Howard L, Annu Rev Cell Dev Biol 2002 18 541 573 10.1146/annurev.cellbio.18.012502.105825 12142271 (Pubitemid 35387361)
2. Endothelial signaling during development. Cleaver O, Melton DA, Nat Med 2003 9 661 668 10.1038/nm0603-661 12778164 (Pubitemid 36749214)
3. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Drake CJ, Fleming PA, Blood 2000 95 1671 1679 10688823 (Pubitemid 30120828)
4. Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Lee JS, Yu Q, Shin JT, Sebzda E, Bertozzi C, Chen M, Mericko P, Stadtfeld M, Zhou D, Cheng L, Graf T, MacRae CA, Lepore JJ, Lo CW, Kahn ML, Dev Cell 2006 11 845 857 10.1016/j.devcel.2006.09.006 17141159 (Pubitemid 44804271)
5. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Kuo CT, Veselits ML, Barton KP, Lu MM, Clendenin C, Leiden JM, Genes Dev 1997 11 2996 3006 10.1101/gad.11.22.2996 9367982 (Pubitemid 27508510)
6. Loss of LKLF function results in embryonic lethality in mice. Wani MA, Means RTJ, Lingrel JB, Transgenic Res 1998 7 229 238 10.1023/A:1008809809843 9859212 (Pubitemid 28541847)
7. Krüppel-like factor 2 is required for normal mouse cardiac development. Chiplunkar AR, Lung TK, Alhashem Y, Koppenhaver BA, Salloum FN, Kukreja RC, Haar JL, Lloyd JA, PLoS One 2013 8 54891 10.1371/journal.pone. 0054891 23457456
8. KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration. Wu J, Bohanan CS, Neumann JC, Lingrel JB, J Biol Chem 2008 283 3942 3950 18063572
9. Krüppel-like factor 2 regulates endothelial barrier function. Lin Z, Natesan V, Shi H, Dong F, Kawanami D, Mahabeleshwar GH, Atkins GB, Nayak L, Cui Y, Finigan JH, Jain MK, Arterioscler Thromb Vasc Biol 2010 30 1952 1959 10.1161/ATVBAHA.110.211474 20651277
10. Dynamic expression of Krüppel-like factor 4 (Klf4), a target of transcription factor AP-2alpha during murine mid-embryogenesis. Ehlermann J, Pfisterer P, Schorle H, Anat Rec A: Discov Mol Cell Evol Biol 2003 273 677 680 12845703 (Pubitemid 37238388)
11. Klf4 is a transcription factor required for establishing the barrier function of the skin. Segre JA, Bauer C, Fuchs E, Nat Genet JID-9216904 1999 22 356 360 10.1038/11926 (Pubitemid 29369526)
12. Krüppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, Owens GK, J Biol Chem 2005 280 9719 9727 15623517 (Pubitemid 40409670)
13. Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Yoshida T, Kaestner KH, Owens GK, Circ Res 2008 20 102 1548 1557
14. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Kawai-Kowase K, Owens GK, Am J Physiol Cell Physiol 2007 292 59 C69 16956962
15. Smooth and cardiac muscle-selective knock-out of Krüppel-like factor 4 causes postnatal death and growth retardation. Yoshida T, Gan Q, Franke AS, Ho R, Zhang J, Chen YE, Hayashi M, Majesky MW, Somlyo AV, Owens GK, J Biol Chem 2010 285 21175 21184 10.1074/jbc.M110.112482 20439457
16. Krüppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Yoshida T, Gan Q, Owens GK, Am J Physiol Cell Physiol 2008 295 1175 C1182 10.1152/ajpcell.00288.2008 18768922 (Pubitemid 352790337)
17. Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Dekker RJ, van Thienen JV, Rohlena J, de Jager SC, Elderkamp YW, Seppen J, de Vries CJ, Biessen EA, van Berkel TJ, Pannekoek H, Horrevoets AJ, Am J Pathol 2005 167 609 618 10.1016/S0002-9440(10) 63002-7 16049344 (Pubitemid 43026114)
18. Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells. Villarreal G Jr, Zhang Y, Larman HB, Gracia-Sancho J, Koo A, Garcia-Cardena G, Biochem Biophys Res Commun 2010 391 984 989 10.1016/j.bbrc.2009.12.002 19968965
19. A core Klf circuitry regulates self-renewal of embryonic stem cells. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, Lim CA, Robson P, Zhong S, Ng HH, Nat Cell Biol 2008 10 353 360 10.1038/ncb1698 18264089 (Pubitemid 351331023)
20. Mammalian Krüppel-like factors in health and diseases. McConnell BB, Yang VW, Physiol Rev 2010 90 1337 1381 10.1152/physrev.00058.2009 20959618
21. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O, Proc Natl Acad Sci U S A 1996 93 13176 13181 10.1073/pnas.93.23.13176 8917564 (Pubitemid 26382789)
22. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Jin ZG, Ueba H, Tanimoto T, Lungu AO, Frame MD, Berk BC, Circ Res 2003 93 354 363 10.1161/01.RES.0000089257.94002.96 12893742 (Pubitemid 37048248)
23. Occludin: structure, function and regulation. Feldman GJ, Mullin JM, Ryan MP, Adv Drug Deliv Rev 2005 57 883 917 10.1016/j.addr.2005.01.009 15820558 (Pubitemid 40488109)
24. EKLF and KLF2 have compensatory roles in embryonic β-globin gene expression and primitive erythropoiesis. Basu P, Lung TK, Lemsaddek W, Sargent TG, Williams DC Jr, Basu M, Redmond LC, Lingrel JB, Haar JL, Lloyd JA, Blood 2007 110 3417 3425 10.1182/blood-2006-11-057307 17675555 (Pubitemid 350106337)
25. Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Warot X, Fromental-Ramain C, Fraulob V, Chambon P, Dolle P, Development 1997 124 4781 4791 9428414 (Pubitemid 28014381)
26. VEGF-directed blood vessel patterning: from cells to organism. Bautch VL, Cold Spring Harb Perspect Med 2012 2 006452 22951440
27. VEGF-mediated phosphorylation of eNOS regulates angioblast and embryonic endothelial cell proliferation. Gentile C, Muise-Helmericks RC, Drake CJ, Dev Biol 2013 373 163 175 10.1016/j.ydbio.2012.10.020 23103584
28. Endothelial nitric oxide synthase gene expression during murine embryogenesis: commencement of expression in the embryo occurs with the establishment of a unidirectional circulatory system. Teichert AM, Scott JA, Robb GB, Zhou YQ, Zhu SN, Lem M, Keightley A, Steer BM, Schuh AC, Adamson SL, Cybulsky MI, Marsden PA, Circ Res 2008 103 24 33 10.1161/CIRCRESAHA.107.168567 18556578
29. The initiation of blood flow and flow induced events in early vascular development. Jones EA, Semin Cell Dev Biol 2011 22 1028 1035 10.1016/j.semcdb.2011.09.020 22001248
30. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC, Nature 1995 376 62 66 10.1038/376062a0 7596435
31. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Dekker RJ, Boon RA, Rondaij MG, Kragt A, Volger OL, Elderkamp YW, Meijers JC, Voorberg J, Pannekoek H, Horrevoets AJ, Blood 2006 107 4354 4363 10.1182/blood-2005-08-3465 16455954 (Pubitemid 43801361)
32. Krüppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function. Shi H, Sheng B, Zhang F, Wu C, Zhang R, Zhu J, Xu K, Kuang Y, Jameson SC, Lin Z, Wang Y, Chen J, Jain MK, Atkins GB, Am J Physiol Heart Circ Physiol 2013 304 796 H805 10.1152/ajpheart.00712.2012 23335794
33. Biological roles of alpha-fetoprotein during pregnancy and perinatal development. Mizejewski GJ, Exp Biol Med (Maywood) 2004 229 439 463 15169963 (Pubitemid 38736314)
34. Krüppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. Feinberg MW, Cao Z, Wara AK, Lebedeva MA, SenBanerjee S, Jain MK, J Biol Chem 2005 280 38247 38258 10.1074/jbc.M509378200 16169848 (Pubitemid 43853721)
35. The Krüppel-like factor KLF4 is a critical regulator of monocyte differentiation. Feinberg MW, Wara AK, Cao Z, Lebedeva MA, Rosenbauer F, Iwasaki H, Hirai H, Katz JP, Haspel RL, Gray S, Akashi K, Segre J, Kaestner KH, Tenen DG, Jain MK, EMBO J 2007 26 4138 4148 10.1038/sj.emboj.7601824 17762869 (Pubitemid 47462091)